Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Return on Equity (2016 - 2025)

Aptevo Therapeutics (APVO) has disclosed Return on Equity for 10 consecutive years, with 1.7% as the latest value for Q3 2025.

  • Quarterly Return on Equity fell 176.0% to 1.7% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 1.7% through Sep 2025, down 176.0% year-over-year, with the annual reading at 0.08% for FY2023, 2.0% down from the prior year.
  • Return on Equity hit 1.7% in Q3 2025 for Aptevo Therapeutics, up from 5.03% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.22% in Q4 2021 to a low of 5.03% in Q2 2025.
  • Historically, Return on Equity has averaged 0.55% across 5 years, with a median of 0.06% in 2024.
  • Biggest five-year swings in Return on Equity: surged 39bps in 2023 and later plummeted -509bps in 2025.
  • Year by year, Return on Equity stood at 0.22% in 2021, then tumbled by -73bps to 0.06% in 2022, then surged by 53bps to 0.09% in 2023, then decreased by -28bps to 0.07% in 2024, then tumbled by -2675bps to 1.7% in 2025.
  • Business Quant data shows Return on Equity for APVO at 1.7% in Q3 2025, 5.03% in Q2 2025, and 3.95% in Q1 2025.